Literature DB >> 2804070

Metabolism of apolipoprotein A-IV in rat.

G Ghiselli1, W L Crump, R Musanti, B C Sherrill, A M Gotto.   

Abstract

The metabolism of apolipoprotein A-IV (apo-IV) has been investigated in the rat. In this animal species, apoA-IV is a major protein constituent of plasma HDL and lymph chylomicron. The apolipoprotein is also present in the lipoprotein-deficient fraction (LDF) of plasma and lymph. In vivo studies with the radioiodinated protein showed the apoA-IV does not exchange freely between HDL and LDF and that LDF apoA-IV had a faster catabolism than HDL apoA-IV. ApoA-IV in chylomicrons is a direct precursor of apoA-IV in plasma HDL but not of that in LDF. On the other hand lymph LDF apoA-IV is an important precursor of plasma LDF apoA-IV. Transfer of apoA-IV from plasma to lymph is negligible, and since most of apoA-IV in lymph is present in LDF, we speculate that LDF apoA-IV is the major apoA-IV secretory product of the intestine. Studies aimed at identifying the site of catabolism of apoA-IV utilizing either radioiodinated or [14C]sucrose labelled apoA-IV, gave results consistent with the view that the liver plays a major role. When tested, human apoA-IV behaved in vivo in rat as the autologous protein. These findings, together with others previously published (Ghiselli, G. et al. (1987) J. Lipid Res. 27, 813-827), support the conclusion that the plasma metabolism of apoA-IV is remarkably similar in rat and human. We speculate that in mammals the rapid plasma catabolism of apoA-IV is mediated by an efficient uptake by the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804070     DOI: 10.1016/0005-2760(89)90319-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin.

Authors:  Aditya Dandekar; Yining Qiu; Hyunbae Kim; Jiemei Wang; Xia Hou; Xuebao Zhang; Ze Zheng; Roberto Mendez; Fu-Shin Yu; Ashok Kumar; Deyu Fang; Fei Sun; Kezhong Zhang
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

2.  Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.

Authors:  Xiaoming Li; Min Xu; Fei Wang; Alison B Kohan; Michael K Haas; Qing Yang; Danwen Lou; Silvana Obici; W Sean Davidson; Patrick Tso
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

3.  Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.

Authors:  K Fujimoto; K Fukagawa; T Sakata; P Tso
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line.

Authors:  Xiaoming Li; Min Xu; Fei Wang; Yong Ji; W Sean DavidsoN; Zongfang Li; Patrick Tso
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.